Evidence map›Paper›PMID 33267860›Full record

Trial reportBMC public health2020

Acceptability of a feasibility randomized clinical trial of a microenterprise intervention to reduce sexual risk behaviors and increase employment and HIV preventive practices (EMERGE) in young adults: a mixed methods assessment.

Larissa Jennings Mayo-Wilson, Jessica Coleman, Fatmata Timbo, Carl Latkin, Elizabeth R Torres Brown, Anthony I Butler, Donaldson F Conserve, Nancy E Glass

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMC public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03766165 (The Engaging Microenterprise for Resource Generation and Health Empowerment), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03766165 nacompletednot on this map

The Engaging Microenterprise for Resource Generation and Health Empowerment (EMERGE) Project: Feasibility Trial of an Enhanced Microenterprise Intervention to Reduce Sexual Risk Behaviors in Young Adults

TypeinterventionalSponsorJohns Hopkins Bloomberg School of Public HealthRan2018 to 2019Enrolled38ConditionsFeasibilityArmsIntervention, Control
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Larissa Jennings Mayo-WilsonDepartment of Applied Health Science, Indiana University School of Public Health, 1025 E. 7th Street, Bloomington, IN, 47405, USA. ljmayowi@iu.edu.
Jessica ColemanDepartment of International Health, Johns Hopkins University School of Public Health, 615 N. Wolfe Street, Baltimore, MD, USA.
Fatmata TimboDepartment of International Health, Johns Hopkins University School of Public Health, 615 N. Wolfe Street, Baltimore, MD, USA.
Carl LatkinDepartment of International Health, Johns Hopkins University School of Public Health, 615 N. Wolfe Street, Baltimore, MD, USA.
Elizabeth R Torres BrownHEBCAC Youth Opportunity (YO!) Program, Johns Hopkins University School of Medicine, 1212 N. Wolfe Street, Baltimore, MD, USA.
Anthony I ButlerAIRS, Inc., Empire Homes of Maryland, Inc., City Steps, 1800 N Charles Street, 7th Floor, Baltimore, MD, USA.
Donaldson F ConserveDepartment of Health Promotion, Education, and Behavior, Arnold School of Public Health, University of South Carolina, 915 Green Street, Columbia, SC, 29208, USA.
Nancy E GlassDepartment of International Health, Johns Hopkins University School of Public Health, 615 N. Wolfe Street, Baltimore, MD, USA.
Johns Hopkins University · USIndiana University Bloomington · USUniversity of South Carolina · US

Funding

QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Integrating Microenterprise and Behavioral Economics for HIV Prevention in African-American Young AdultsK01MH107310 · NIMH · TRUSTEES OF INDIANA UNIVERSITY · PI JENNINGS MAYO-WILSON, LARISSA · 2015 to 2019
$848k
Johns Hopkins Institute for Clinical and Translational Research UL1TR003098NCATS NIH HHS UL1 TR003098NIMH NIH HHS K01 MH107310NIMH NIH HHS K01MH107310
6 · The paper itself

Abstract

backgroundAcceptability is a critical requisite in establishing feasibility when planning a larger effectiveness trial. This study assessed the acceptability of conducting a feasibility randomized clinical trial of a 20-week microenterprise intervention for economically-vulnerable African-American young adults, aged 18 to 24, in Baltimore, Maryland. Engaging MicroenterprisE for Resource Generation and Health Empowerment (EMERGE) aimed to reduce sexual risk behaviors and increase employment and uptake of HIV preventive behaviors.

methodsThirty-eight participants were randomized to experimental (n = 19) or comparison group (n = 19). The experimental group received text messages on job openings plus educational sessions, mentoring, a start-up grant, and business and HIV prevention text messages. The comparison group received text messages on job openings only. Qualitative and quantitative post-intervention, in-person interviews were used in addition to process documentation of study methods.

resultsOur results found that the study design and interventions showed promise for being acceptable to economically-vulnerable African-American young adults. The largely positive endorsement suggested that factors contributing to acceptability included perceived economic potential, sexual health education, convenience, incentives, and encouraging, personalized feedback to participants. Barriers to acceptability for some participants included low cell phone connectivity, perceived payment delays, small cohort size, and disappointment with one's randomization assignment to comparison group. Use of peer referral, network, or wait-list designs, in addition to online options may enhance acceptability in a future definitive trial. Expanding administrative and mentoring support may improve overall experience.

conclusionMicroenterprise interventions are acceptable ways of providing young adults with important financial and sexual health content to address HIV risks associated with economic vulnerability.

trial registrationClinicalTrials.gov. NCT03766165 . Registered 04 December 2018.

Indexed as

Health Risk BehaviorsSexual BehaviorSmall BusinessAdolescentAdultBaltimoreBlack or African AmericanCell PhoneEmploymentFeasibility StudiesFemaleHIV InfectionsHumansMaleMiddle AgedMotivationAcceptabilityAfrican-AmericanBaltimoreClinical trialEconomicHIVMicroenterpriseQualitativeSexual risk behaviorsText messagesYoung adults

Identifiers

PMID33267860
PMCPMC7709242
OpenAlexW3108088549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.